These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Investigation of the role of the base in the synthesis of [18F]FLT. Suehiro M; Vallabhajosula S; Goldsmith SJ; Ballon DJ Appl Radiat Isot; 2007 Dec; 65(12):1350-8. PubMed ID: 17919915 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of 4-(5-[18F]fluoromethyl-3-phenylisoxazol-4-yl)benzenesulfonamide, a new [18F]fluorinated analogue of valdecoxib, as a potential radiotracer for imaging cyclooxygenase-2 with positron emission tomography. Toyokuni T; Kumar JS; Walsh JC; Shapiro A; Talley JJ; Phelps ME; Herschman HR; Barrio JR; Satyamurthy N Bioorg Med Chem Lett; 2005 Nov; 15(21):4699-702. PubMed ID: 16153836 [TBL] [Abstract][Full Text] [Related]
4. Is there a future for clinical fluorine-18 radiopharmaceuticals (excluding FDG)? Stöcklin GL Eur J Nucl Med; 1998 Dec; 25(12):1612-6. PubMed ID: 9917190 [TBL] [Abstract][Full Text] [Related]
5. The future of positron emission tomography in oncology depends on interactive basic, nuclear and clinical research. Buell U; Cremerius U; Zimny M Eur J Nucl Med; 1997 Oct; 24(10):1330. PubMed ID: 9432468 [No Abstract] [Full Text] [Related]
6. Lesion detectability and quantitative recovery with FDG-PET. Links JM Eur J Nucl Med; 1999 Jun; 26(6):681-2. PubMed ID: 10428608 [No Abstract] [Full Text] [Related]
7. New 18F-radiopharmaceuticals. Stöcklin G Nuklearmedizin; 1990 Mar; 29(2):80. PubMed ID: 2339087 [No Abstract] [Full Text] [Related]
8. [Whole body positron emission tomography (PET) with (18F)-fluorodeoxyglucose]. Grupo PET de la SEMN Rev Esp Med Nucl; 2002 Apr; 21(2):128-30. PubMed ID: 11879625 [No Abstract] [Full Text] [Related]